Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...

While there is no definitive evidence linking chemicals to increased cancer risk in young people, this is an area of intense ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

UC San Diego study of global lung cancer shows mutations that lead to cancer are common in people who live in cities with bad air pollution. But cancer mutations are quite close to normal among ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

Douglas McIntyre, Editor-in-Chief at Climate Crisis 24/7, reports on new findings linking air pollution to lung cancer in non ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

In a primary efficacy population of 85 patients, the confirmed overall response rate was 46%.

Immuneering Corporation’s investigational MEK inhibitor aims to outpace cancer while reducing resistance and side effects.

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most undervalued large cap stocks to buy according to analysts.

One of the ways to detect cancer early is by undergoing regular screenings. There are different types of tests that one can get done that can help understanding the risks and in early diagnosis. Here ...